Sfoglia per AUTORE
JOHNSON P
Collezione ASL Biella

  

Items : 8

Impact of different induction regimens on the outcome of primary mediastinal b cell lymphoma in the prospective IELSG 37 trial in Hematological Oncology

2021
ASL Biella
AOU Città della Salute di Torino
AOU Alessandria

Kryachok I; Ceriani L; Balzarotti M; Tucci A; Cabras MG; Zilioli VR; Rusconi C; Angrilli F; Arcaini L; Dabrowska Iwanicka A; Ferreri AJM; Merli F; Zhao W; Hodgson D; Ionescu C; Fosså A; Cwynarski K; Mikhaeel G; Jerkeman M; Janikova A; Hüttmann A; Ciccone G; Metser U; Barrington S; Malkowski B; Versari A; Esposito F; Cozens K; Ielmini N; et alii...

Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment. in Haematologica / Haematologica. 2020 Nov 1;105(11):2592-2597. doi: 10.3324/haematol.2019.237990.

2020
ASL Biella

Zucca E; Johnson PW; Cavalli F; Lopez Guillermo A; Raderer M; Gaidano G; Margiotta Casaluci G; Kiesewetter B; Torri V; Cascione L; Conconi A; Thieblemont C;

Early progression of disease (POD24) as survival predictor in MALT lymphoma in Journal of Clinical Oncology

2019
ASL Biella

Conconi A; Thieblemont C; Cascione L; Torri V; Kiesewetter B; Margiotta-Casaluci G; Gaidano G; Raderer M; Cavalli F; Lopez-Guillermo A; Johnson PWM; Zucca E;

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma. in Blood / Blood. 2018 Jul 12;132(2):179-186. doi: 10.1182/blood-2018-01-826958. Epub 2018 May 2.

2018
ASL Biella

Cozens K; Porro E; Giovanella L; Bellei M; Cavalli F; Conconi A; Stathis A; Di Rocco A; Zinzani PL; Cascione L; Ferreri AJM; Martelli M; Zucca E; Johnson PW; Milan L; Ceriani L;

A MALT lymphoma prognostic index. in Blood / Blood. 2017 Sep 21;130(12):1409-1417. doi: 10.1182/blood-2017-03-771915. Epub 2017 Jul 18.

2017
ASL Biella

Zucca E; Torri V; Cavalli F; Johnson PW; Lopez Guillermo A; Coiffier B; Laszlo D; Martelli M; Gaidano G; Kiesewetter B; Raderer M; Conconi A; Cascione L; Thieblemont C;

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29.

2017
ASL Biella
AOU Città della Salute di Torino

Thieblemont C; Johnson P; Cavalli F; Mazzucchelli L; Campo E; Jack A; Moreau A; Ponzoni M; Bellei M; Stelitano C; Haioun C; Bosly A; Zachée P; Ferreri AJM; Hohaus S; Torri V; Tilly H; Morschhauser F; Devizzi L; Pinotti G; Guillermo AL; Sebban C; Salles G; Pettengell R; Martelli M; Vitolo U; Tucci A; Martinelli G; Bouabdallah R; et alii...

Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study. in British journal of haematology / Br J Haematol. 2017 Aug;178(4):588-591. doi: 10.1111/bjh.14728. Epub 2017 May 9.

2017
ASL Biella
AOU Città della Salute di Torino

Johnson PWM; Zucca E; Rigacci L; Giovanella L; Cabras MG; Gotti M; Stelitano C; Botto B; Ferreri AJM; Zinzani PL; Conconi A; Martelli M; Ceriani L;

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). in The oncologist / Oncologist. 2015 Oct;20(10):1149-53. doi: 10.1634/theoncologist.2015-0180. Epub 2015 Aug 12.

2015
ASL Biella

Nowakowski GS; Cavalli F; Habermann TM; Ristow K; Mazzucchelli L; Campo E; Jack A; Pileri SA; Copie-Bergman C; McPhail ED; Thieblemont C; Martinelli G; Martelli M; Johnson PW; Lopez Guillermo A; Gaidano G; Cortelazzo S; Conconi A; Porro E; Pangalis GA; Stathis A; Kalpadakis C; Mian M; Zucca E; Jackson AE;